SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-214062
Filing Date
2019-08-06
Accepted
2019-08-06 16:07:04
Documents
14
Period of Report
2019-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d779978d8k.htm   iXBRL 8-K 26610
2 EX-99.1 d779978dex991.htm EX-99.1 126661
6 GRAPHIC g779978g0806170512037.jpg GRAPHIC 4286
  Complete submission text file 0001193125-19-214062.txt   294843

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gwph-20190806.xsd EX-101.SCH 3041
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gwph-20190806_lab.xml EX-101.LAB 18063
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gwph-20190806_pre.xml EX-101.PRE 11356
7 EXTRACTED XBRL INSTANCE DOCUMENT d779978d8k_htm.xml XML 3512
Mailing Address SOVEREIGN HOUSE VISION PARK HISTON, CAMBRIDGE CB24 9BZ X0 00000
Business Address SOVEREIGN HOUSE VISION PARK HISTON, CAMBRIDGE CB24 9BZ X0 00000 44 1223 266800
GW PHARMACEUTICALS PLC (Filer) CIK: 0001351288 (see all company filings)

IRS No.: 000000000
Type: 8-K | Act: 34 | File No.: 001-35892 | Film No.: 191002107
SIC: 2834 Pharmaceutical Preparations